LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹47 Cr | ₹38 Cr | ₹33 Cr | ₹99 Cr | ₹50 Cr |
What is the latest Total Current Liabilities ratio of LYKA LABS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹47 Cr |
Mar2024 | ₹38 Cr |
Mar2023 | ₹33 Cr |
Mar2022 | ₹99 Cr |
Mar2021 | ₹50 Cr |
How is Total Current Liabilities of LYKA LABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹47 Cr | 23.45 | |
Mar2024 | ₹38 Cr | 15.87 | |
Mar2023 | ₹33 Cr | -67.19 | |
Mar2022 | ₹99 Cr | 99.18 | |
Mar2021 | ₹50 Cr | - |
Compare Total Current Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹396.1 Cr | 0.1% | -2.4% | -3.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | 0.1% |
-2.4% |
-3.3% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses